AzTrials
AzTrials

StrokeNCT06183970

Recovery of Motor Skills With the Use of Artificial Intelligence and Computer Vision

A study testing AssistI patients and Habilect patients in people with Stroke and Hemiparesis, run by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To investigate the impact of algorithms utilizing artificial intelligence technology and computer vision on the recovery of motor functions within the context of rehabilitation practice for patients who have experienced a cerebral stroke. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
What is being tested?
AssistI patients and Habilect patients
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
No sites listed yet
Study dates
Feb 2024to Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Recent hemispheric stroke (ischemic or hemorrhagic):
  • Rankin scale: 3
  • Within 6 months post stroke.
  • Upper limb hemiparesis with strength ≤3 points proximally.
  • Muscle tone rise (≤3 points) on Ashford scale.
  • Complex sensitivity preserved per neuro examination

Who cannot join

  • Rankin scale of 4 points and higher.
  • 6 months or more after undergoing stroke.
  • Structural changes in the joints of the upper extremities that limit joint mobility (contractures, ankylosis, metal structures that limit mobility).
  • Severe pain syndrome in the paretic upper limb at rest or when moving, preventing exercise (7 points or more on the scale).
  • Gross cognitive disorders, psychoemotional arousal, signs of hysteria, pseudobulbar syndrome (violent laughter, crying), aphasic disorders that prevent understanding of the task.
  • Visual disturbances that prevent the perception of information (neglect, hemianopia, myopia, diplopia).
  • Thrombosis of the veins in the upper and lower extremities without signs of recanalization, or arterial thrombosis.
  • Parkinsonism and other types of tremor.

Trial locations and contacts

No sites are listed yet.

Bogdan Ragulin contact

+79255053658

5053658@gmail.com

About this study

Official title: Recovery of Motor Functions Through Assistive Motion Capture Software Using Artificial Intelligence and Computer Vision

To investigate the impact of algorithms utilizing artificial intelligence technology and computer vision on the recovery of motor functions within the context of rehabilitation practice for patients who have experienced a cerebral stroke.

Read the detailed description

Progress in artificial intelligence (AI) technologies and their practical application across various fields, notably in medicine, showcases their potential in solutions such as automated diagnostic systems, unstructured medical record recognition, natural language understanding, event analysis and prediction, information classification, automatic patient support via chatbots, and movement analysis through video. Currently, diverse AI-based software systems are being developed, designed to solve intellectual problems akin to human thinking. AI's widespread applications encompass prediction, evaluation of digital information (including unstructured data), and pattern recognition (data mining).

Amid rapid advancements in deep machine learning, particularly in image and pattern recognition, medical image analysis has gained prominence within automated diagnostic systems, particularly in radiation diagnostics. With the burgeoning field's rapid growth, curating medical datasets for AI-based diagnostic system training and validation is crucial.

AI's success in radiation diagnostics and its recognition as promising within scientific circles pave the way for video analysis and machine learning's integration into medical rehabilitation practice. Collaborating, researchers at the Federal Medical Research Center of the FMBA of Russia and MTUCI devised a plan to develop specialized algorithms based on video movement analysis and machine learning for stroke patients undergoing medical rehabilitation.

These algorithms monitor patients' movements and promptly notify them of deviations, amplitude reductions, or compensatory patterns, aiding them in correcting their movements. All session data is archived electronically, accessible to medical professionals responsible for individualized lesson plans. This enables assessment of patient progress and necessary adjustments to the home rehabilitation program.

Incorporating AI-driven video analysis and machine learning into medical rehabilitation holds great potential for enhancing patient outcomes and personalizing treatment strategies.

Being tested
AssistI patients, Habilect patients
Keywords
Rehabilitation, Artificial intelligence, Computer vision, Motion capture, Assistive technology
Medical subject headings
Stroke, Paresis, Cerebellar Ataxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AssistI patientsDevice

    The AsistI software package rehabilitation involves tailored upper limb exercises under an individual program. The regimen consists of 10-12 sessions, each lasting 30 minutes. Patients execute 10 exercises sequentially with their unaffected and affected limbs, involving tasks like touching mouth, forehead, and trunk parts with hand's brush, and amplitude movements in upper limb joints. AsistI assesses exercise accuracy, prevents unfavorable patterns, and logs target achievement, considering speed, accuracy, and repetitions.

  • Habilect patientsDevice

    The Habilect rehab program involves 10-12 sessions using software and hardware. Patients perform upper limb exercises for 30 minutes individually, focusing on specific movements. They repeat 10 exercises, first with the healthy limb, then the affected one. Tasks include touching mouth, forehead, and trunk, along with joint movements like shoulder flexion. Habilect assesses exercise accuracy, preventing wrong moves, and tracks progress, considering speed, accuracy, repetitions.

Study groups in NCT06183970
Study groupRoleWhat they receive
AssistI patientsExperimentalPatients will receive rehabilitation training using the AsistI software package in conjunction with standard upper limb rehabilitation interventions.
Receives: Device: AssistI patients
Habilect patientsActive comparatorPatients will receive rehabilitation training using the Habilect software and hardware complex, in addition to standard rehabilitation interventions for the upper limb.
Receives: Device: Habilect patients
Conventional therapy patientsNo interventionPatients will undergo standard upper limb rehabilitation interventions without the utilization of additional methods.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment Scale for upper extremity assessment (FMA-UE)

    In this study, we wiil use 36 items of the upper arm (proximal musculature, FMA-UA), 24 items of wrist and hand (distal musculature, FMA-W/H), 6 items of aspects of coordination, 12 items of aspects of sensation, 24 items of aspects of passive joint movement, 24 items of joint pain. So the maximum total score on this FMA-UE scale was 126 points.

    Measured: Change from baseline at 3 weeks

  2. Muscle strength was assessed using the MRC (Medical Research Council Weakness Scale)

    MRC is a commonly used scale for assessing muscle strength from Grade 5 (normal) to Grade 0 (no visible contraction). Paresis is defined as light at compliance with strength 4 points, moderate - 3 points, pronounced - 2 points, rough - 1 point and with - 0 points.

    Measured: Change from baseline at 3 weeks

  3. The Action Research Arm Test (ARAT)

    Is a 19 item observational measure used by physical therapists and other health care professionals to assess upper extremity performance (coordination, dexterity and functioning) in stroke recovery, brain injury and multiple sclerosis populations. Scores on the ARAT may range from 0-57 points, with a maximum score of 57 points indicating better performance. MCID has been suggested as 5.7 points

    Measured: Change from baseline at 3 weeks

Secondary outcomes (6)
  1. The speed of movement of the upper limb

    Upper limb movement speed: Time to reach the target (sec).

    Measured: Change from baseline at 3 weeks

  2. Accuracy of performed movements

    Movement accuracy: Precision in touching guided points (angles).

    Measured: Change from baseline at 3 weeks

  3. Total number of repetitions

    Repetition count: Number of motor attempts for the goal.

    Measured: Change from baseline at 3 weeks

  4. The correctness of the exercises

    Exercise correctness: Number of compensatory actions like shoulder elevation or torso bend.

    Measured: Change from baseline at 3 weeks

  5. The number of exercises completed

    Correct repetition count: Number of attempts without compensation, e.g., shoulder or torso movements.

    Measured: Change from baseline at 3 weeks

  6. The number of exercises not completed

    Incorrect repetition count: Number of attempts with compensatory actions, e.g., shoulder lift or torso bend.

    Measured: Change from baseline at 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2023
  2. Study startFeb 2024 (estimated)
  3. Primary completionAug 2024 (estimated)
  4. Study completionFeb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06183970
Sponsor's protocol ID
AssistI01
Status last verified
Aug 2023
First submitted
24 Aug 2023
Last updated
28 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing AssistI patients and Habilect patients in people with Stroke and Hemiparesis, run by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Danila Lobunko (+79091648192, doctorlobunko@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment Scale for upper extremity assessment (FMA-UE) (time frame: Change from baseline at 3 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in